Alnylam Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Period Activity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to Alnylam Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Period Activity

Alnylam Pharma (ALNY) Tops Q3 EPS by 15c, Misses on Revenue, Offers FY22 Revenue Guidance

October 27, 2022 8:03 AM EDT

Alnylam Pharma (NASDAQ: ALNY) reported Q3 EPS of ($1.58), $0.15 better than the analyst estimate of ($1.73). Revenue for the quarter came in at $264.3 million versus the consensus estimate of $293.08 million.

GUIDANCE:

Alnylam Pharma sees FY2022 revenue of $870-930 million, versus the consensus of... More